Ardent Health(ARDT.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Ardent Health
ARDT.US
Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers, urgent care centers, free-standing emergency departments, and diagnostic imaging centers.
183.20 B
ARDT.USMarket value -Rank by Market Cap -/-

Financial Score

15/01/2026 Update
B
Health Care FacilitiesIndustry
Industry Ranking10/23
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE18.28%A
    • Profit Margin3.24%C
    • Gross Margin57.07%B
  • Growth ScoreB
    • Revenue YoY10.86%B
    • Net Profit YoY122.92%A
    • Total Assets YoY7.38%B
    • Net Assets YoY17.66%A
  • Cash ScoreB
    • Cash Flow Margin3084.75%A
    • OCF YoY10.86%B
  • Operating ScoreA
    • Turnover1.27A
  • Debt ScoreD
    • Gearing Ratio68.34%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    21:30 ET ARDT Investors Have Opportunity to Lead Ardent Health, Inc. Securities Fraud Lawsuit

    Rosen Law Firm has announced a class action lawsuit for investors who purchased securities of Ardent Health, Inc. (NYSE: ARDT) between July 18, 2024, and November 12, 2025. Investors may be entitled to compensation without upfront fees. The lawsuit claims misrepresentations regarding Ardent Health's accounts receivable and insufficient malpractice liability insurance. Interested investors can join the class action by contacting Phillip Kim, Esq. by March 9, 2026, to serve as lead plaintiff. No class has been certified yet, and investors can choose their counsel or remain absent.

    prnewswire·
    US
    ARDT
    -1.70%
    prnewswire·
    US
    ARDT
    -1.70%

    18:49 ET Ardent Health (ARDT) Hit With Securities Class Action Amid Receivables and Reserves Issues Driving 33% Plunge - Hagens Berman

    A securities class action lawsuit has been filed against Ardent Health, Inc. (NYSE: ARDT) following significant accounting adjustments of about $90 million revealed in Q3 2025 disclosures, leading to a 33% drop in stock price. The lawsuit claims Ardent's leadership failed to disclose material weaknesses in internal controls related to revenue recognition and reserves. Investors who suffered losses between July 18, 2024, and November 12, 2025, are encouraged to contact Hagens Berman for representation. The case raises questions about the company's revenue accounting practices and the awareness of leadership regarding these issues.

    prnewswire·
    US
    ARDT
    -1.70%
    prnewswire·
    US
    ARDT
    -1.70%

    Ardent Health Corporation Securities Fraud Class Action Result of Undisclosed Financial Problems and 33% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

    Ardent Health Corporation faces a securities fraud class action lawsuit due to undisclosed financial issues, leading to a 33% stock decline. Investors who purchased shares between July 18, 2024, and November 12, 2025, have until March 9, 2026, to file lead plaintiff applications. The lawsuit alleges that Ardent failed to disclose material information, resulting in a significant drop in share price after revealing a $43 million revenue decrease and a cut in EBITDA guidance. Kahn Swick & Foti, LLC is representing affected investors.

    Acceswire·
    US
    ARDT
    -1.70%
    Acceswire·
    US
    ARDT
    -1.70%

    12:00 ET Bronstein, Gewirtz & Grossman LLC Urges Ardent Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

    Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Ardent Health, Inc. (NYSE: ARDT) on behalf of investors who purchased securities between July 18, 2024, and November 12, 2025. The lawsuit alleges that Ardent made false statements regarding its financial performance, including overstated revenue and EBITDA guidance. Investors are encouraged to join the case and can contact the firm for more information. The firm operates on a contingency fee basis, meaning no upfront costs for investors.

    prnewswire·
    US
    ARDT
    -1.70%
    prnewswire·
    US
    ARDT
    -1.70%

    Ardent Health (ARDT) Valuation Check After Accounting Revisions Lawsuits And Guidance Cut

    Ardent Health (ARDT) faces challenges after a $43 million revenue revision and a $54 million increase in liability reserves, leading to a cut in 2025 EBITDA guidance. The stock is currently priced at $8.87, reflecting a 43.86% loss over the past year. Analysts suggest a fair value of $13.96, indicating it may be undervalued. However, concerns about execution and margins persist, with a P/E ratio of 6.2x compared to industry averages. Investors are encouraged to assess risks and explore other healthcare stocks for potential opportunities.

    Simplywall·
    US
    ARDT
    -1.70%
    Simplywall·
    US
    ARDT
    -1.70%
    © 2026 Longbridge｜Disclaimer